L61H46 Shows Potent Efficacy Against Human Pancreatic Cancer Through Inhibiting STAT3 Pathway [Erratum]
Bai E, Yang L, Xiang Y, et al. Cancer Manag Res. 2018;10:565–581. During the publication process there was an operator error that resulted in the Western blot images of Figures 5A and 5B on page 575 appearing spliced. Read the original article
Main Authors: | Bai E, Yang L, Xiang Y, Hu W, Li C, Lin J, Dai X, Liang G, Jin R, Zhao C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-12-01
|
Series: | Cancer Management and Research |
Online Access: | https://www.dovepress.com/httpswwwdovepresscomerratum-l61h46-shows-potent-efficacy-against-human-peer-reviewed-article-CMAR |
Similar Items
-
Erratum to: Integrin-FAK signaling rapidly and potently promotes mitochondrial function through STAT3
by: Nishant P. Visavadiya, et al.
Published: (2017-03-01) -
Discovery of the Highly Selective and Potent STAT3 Inhibitor for Pancreatic Cancer Treatment
by: Huang Chen, et al.
Published: (2024-02-01) - L111N C46 (44-61) [fotograf udara]
- L111N C46 (44-61) [fotograf udara]
-
Chloroquine Potentiates the Anticancer Effect of Pterostilbene on Pancreatic Cancer by Inhibiting Autophagy and Downregulating the RAGE/STAT3 Pathway
by: Rong-Jane Chen, et al.
Published: (2021-11-01)